158
staff
Troy Duffie
Troy Duffie is a director of MI Finance at the Milken Institute and has a background in venture c
apital, social impact investing, and affordable housing.
+ Read More
staff
Blair Smith
Blair Smith is senior director of Financial Markets at the Milken Institute, with more than 20 ye
ars of financial services and capital markets experience.
+ Read More
report
Creating a Nonprofit Marketplace for Shelved Drugs: Lessons from a Pilot Project
Many promising medicines, despite strong safety data and pharmaceutical characteristics, are discon
tinued by drug companies for nonscientific reasons, including strategic, organizational, and financial considerations.
+ Read More
report
Hedging Pipeline Risk in Pharma: FDA Swaps and Annuities
The cost of capital to conduct medical R&D is high because investors must be compensated with s
ignificant returns to offset the risky and long drug-development process.
+ Read More
report
Growing the US Green Bond Market: Lab 2
As climate-related events, including wildfires, become more prevalent throughout California, invest
ors and issuers alike are looking for new tools to protect the state from increasingly devastating environmental disasters.
+ Read More
report
Nonprofits: A Growing Force in Drug Development
Shepherding a drug from discovery to the market is a complex process that involves many actors.
report
Stepping off the Sidelines: The Unrealized Potential of Strategic Ultra-High-Net-Worth Philanthropy
The challenges our world is facing today will take a concerted, collaborative effort, and high-impa
ct philanthropists are poised to lead that effort like never before.
+ Read More
report
Patient-Focused Drug Development Meetings: Smart Practices from Community Leaders
FasterCures, a center of the Milken Institute, designed this guide for patient advocacy organizatio
ns that are interested in hosting, or are currently planning, an externally led patient-focused drug development (PFDD)
+ Read More
report
GBM: Giving Smarter
Glioblastoma Multiforme (GBM) is an aggressive malignant brain tumor involving glial cells of the b
rain. At the time of this report, nearly 15,000 people were diagnosed with GBM each year in the United States and Europe.
+ Read More
report
ESG Ratings: The Road Ahead
MI REVIEW ARTICLE
report
State Technology and Science Index 2016: Sustaining Americas Innovation Economy
As the Great Recession recedes in our rearview mirrors, it is becoming ever more apparent that inno
vative activities are determining an increasing proportion of the long-term economic growth of cities, metropolitan areas, regions, states, and even natio
+ Read More
report
Building East Africa’s Future: Tanzania and Accelerating Infrastructure Growth
At the August 2014 U.S.-Africa Leaders Summit, the White House brought together government official
s from 50 African countries.
+ Read More